mhurhangee/patent-ind-claim-en huggingface dataset:
Device for detecting a shape or positioning defect of a hollow body for a unit for thermal conditioning of the hollow body, also known as an oven, the unit comprising one or more radiating walls and a conveyor of the hollow bodies defining at least one rectilinear path (TR), the hollow bodies following the rectilinear path (TR) between an entry point (E) and an exit point (S) of the thermal conditioning unit and each having a main axis (X), the device comprising: - an optical block incorporating an emitter producing an optical beam positioned between the wall of the hollow body and the radiating wall along an optical pathway of which one segment is oriented parallel to the rectilinear path (TR) and offset laterally, with respect to a median plane (M) swept along by the main axes (X) of the nominally positioned hollow bodies , by a distance (D) greater than a half-width (R) of the hollow bodies and less than twice the width (R) of the hollow bodies ; - a target positioned at a distance from the optical block , this target being provided with a photosensitive sensor or a reflector intercepting the optical pathway of the beam and suitable, respectively, for detecting the impact thereof or for reflecting it towards an optical receiver incorporated in the optical block such that, when a hollow body has a shape or positioning defect, it is interposed on the optical pathway between the optical block and the target and is struck by the optical beam between the wall of the hollow body and the radiating wall , resulting in detection of the shape or positioning defect. - an optical block incorporating an emitter producing an optical beam positioned between the wall of the hollow body and the radiating wall along an optical pathway of which one segment is oriented parallel to the rectilinear path (TR) and offset laterally, with respect to a median plane (M) swept along by the main axes (X) of the nominally positioned hollow bodies , by a distance (D) greater than a half-width (R) of the hollow bodies and less than twice the width (R) of the hollow bodies ; - a target positioned at a distance from the optical block , this target being provided with a photosensitive sensor or a reflector intercepting the optical pathway of the beam and suitable, respectively, for detecting the impact thereof or for reflecting it towards an optical receiver incorporated in the optical block such that, when a hollow body has a shape or positioning defect, it is interposed on the optical pathway between the optical block and the target and is struck by the optical beam between the wall of the hollow body and the radiating wall , resulting in detection of the shape or positioning defect.
Method for simultaneously separating a multiplicity of slices from a workpiece by means of a wire saw, comprising a cutting-off grinding operation, wherein a workpiece is fed perpendicularly with respect to a longitudinal axis of the workpiece against a wire gate , tensioned between two wire guide rollers , of a saw wire which is moved in the longitudinal direction of the saw wire , wherein a cooling lubricant is fed to the wire gate , and wherein slices which are attached to a bar and between which there are separation gaps are formed between wire portions of the wire gate ; the extraction of the bar and the slices from the wire gate, and, during the extraction of the bar and the slices , the spraying of the separation gaps with a liquid by means of a spraying device until the wire portions have left the separation gaps , wherein the liquid is supplied under high pressure through nozzles , characterized in that that the nozzles are attached to nozzle bars which are moved in an oscillating manner parallel to the longitudinal axis of the workpiece , wherein the liquid and entrained air cause the slices to vibrate temporarily.
An autoinjector comprising: a case ; a syringe ; a motor adapted to rotate a drive gear ; a curvi-linear plunger adapted to mate with the drive gear , wherein the plunger includes a distal end with a resilient flange (18.1) having ramped or rounded edges, wherein a first diameter of the resilient flange (18.1) is larger than a second diameter of a proximal opening of a syringe body of the syringe , wherein when the motor rotates the drive gear the plunger is advanced such that the resilient flange (18.1) being in a non-deflected state abuts a proximal collar (5.2) of the syringe and pushes the syringe in a distal direction, wherein when the syringe abuts a distal stop in the case , a needle is extended through an aperture (3.1) and continued rotation of the drive gear causes the resilient flange (18.1) to deflect resulting in a deflected state, in which the resilient flange (18.1) advances through the proximal collar (5.2) and engages a stopper in the syringe pushing the stopper distally to dispense the medicament through the needle . a case ; a syringe ; a motor adapted to rotate a drive gear ; a curvi-linear plunger adapted to mate with the drive gear , wherein the plunger includes a distal end with a resilient flange (18.1) having ramped or rounded edges, wherein a first diameter of the resilient flange (18.1) is larger than a second diameter of a proximal opening of a syringe body of the syringe , wherein when the motor rotates the drive gear the plunger is advanced such that the resilient flange (18.1) being in a non-deflected state abuts a proximal collar (5.2) of the syringe and pushes the syringe in a distal direction, wherein when the syringe abuts a distal stop in the case , a needle is extended through an aperture (3.1) and continued rotation of the drive gear causes the resilient flange (18.1) to deflect resulting in a deflected state, in which the resilient flange (18.1) advances through the proximal collar (5.2) and engages a stopper in the syringe pushing the stopper distally to dispense the medicament through the needle .
Method for the computer-aided open-loop and/or closed-loop control of the operation of an energy generation system, in particular of a combined power plant for energy generation and seawater desalination, having the steps: building (S1) a simulation model of the energy generation system; providing (S2) an efficiency calculation module which is designed to calculate the expected thermal and electrical efficiency of the energy generation system on the basis of the built simulation model and using predetermined operating parameters; applying (S3) a learning and/or optimization method to the provided efficiency calculation module using known operating data of the energy generation system and/or on the basis of simulation data obtained by the simulation model in such a way that the operation of the energy generation system is optimized in terms of at least one thermal and/or electrical operating parameter in accordance with a target value, wherein the application (S3) is performed using one or more decision trees and/or based on a particle swarm optimization; building (S4) an open-loop control strategy for the energy generation system on the basis of the trained efficiency calculation module; and operating (S5) the energy generation system using the built open-loop control strategy. building (S1) a simulation model of the energy generation system; providing (S2) an efficiency calculation module which is designed to calculate the expected thermal and electrical efficiency of the energy generation system on the basis of the built simulation model and using predetermined operating parameters; applying (S3) a learning and/or optimization method to the provided efficiency calculation module using known operating data of the energy generation system and/or on the basis of simulation data obtained by the simulation model in such a way that the operation of the energy generation system is optimized in terms of at least one thermal and/or electrical operating parameter in accordance with a target value, wherein the application (S3) is performed using one or more decision trees and/or based on a particle swarm optimization; building (S4) an open-loop control strategy for the energy generation system on the basis of the trained efficiency calculation module; and operating (S5) the energy generation system using the built open-loop control strategy.
Timepiece comprising a striking mechanism which can operate in a repeater mode or alarm mode, a mechanical energy source to supply the striking mechanism with power and manual control members to control the striking mechanism , the striking mechanism being arranged to produce an audible indication of the current time when the repeater mode is activated and to produce, at a specified alarm time, an audible indication of said alarm time when the alarm mode is activated, characterised in that the manual control members comprise a first manual control member making it possible to select either the repeater mode or the alarm mode, and a second manual control member making it possible to wind the mechanical energy source and to activate the selected mode.
An apparatus comprising: a) a housing ; b) a chamber disposed in the housing , the chamber configured to be adaptable to each of an open configuration, a closed configuration, and a hermetically sealed configuration, wherein the chamber comprises a material transparent to actinic radiation; c) at least two light emitting diodes, LEDs, disposed within the housing , wherein light from the at least two LEDs enters the chamber from more than one direction; d) a vacuum pump operatively connected to the chamber ; and e) a user interface disposed on an exterior of the housing , the user interface comprising a display and a plurality of program switches configured to adjust at least three operational parameters of the apparatus , wherein the at least three operational parameters comprise 1) light intensity provided by the at least two LEDs , 2) length of time of light provided by the at least two LEDs , and at least one of 3a) delay time between initiation of light provided by the at least two LEDs and initiation of vacuum pulled on an interior of the chamber by the vacuum pump or 3b) delay time between initiation of vacuum pulled on an interior of the chamber by the vacuum pump and initiation of light provided by the at least two LEDs. a) a housing ; b) a chamber disposed in the housing , the chamber configured to be adaptable to each of an open configuration, a closed configuration, and a hermetically sealed configuration, wherein the chamber comprises a material transparent to actinic radiation; c) at least two light emitting diodes, LEDs, disposed within the housing , wherein light from the at least two LEDs enters the chamber from more than one direction; d) a vacuum pump operatively connected to the chamber ; and e) a user interface disposed on an exterior of the housing , the user interface comprising a display and a plurality of program switches configured to adjust at least three operational parameters of the apparatus , wherein the at least three operational parameters comprise 1) light intensity provided by the at least two LEDs , 2) length of time of light provided by the at least two LEDs , and at least one of 3a) delay time between initiation of light provided by the at least two LEDs and initiation of vacuum pulled on an interior of the chamber by the vacuum pump or 3b) delay time between initiation of vacuum pulled on an interior of the chamber by the vacuum pump and initiation of light provided by the at least two LEDs.
A method for assembling a silicon part to a hub , the silicon part comprising a central through opening , an internal edge delimiting the central through opening and at least one notch extending from the internal edge , and the hub comprising a deformable portion, the method comprising steps of: placing the hub inside the central opening , bringing a tool into contact with the deformable portion; plastically deforming the deformable portion by mechanically biasing the deformable portion using the tool , such that once deformed, the deformable portion extends against the part by forming a stop holding the part in position on the hub , wherein the plastic deformation step has the effect of deforming the hub by forming a boss to fill a space of the notch , so as to rotatably block the hub on the part . placing the hub inside the central opening , bringing a tool into contact with the deformable portion; plastically deforming the deformable portion by mechanically biasing the deformable portion using the tool , such that once deformed, the deformable portion extends against the part by forming a stop holding the part in position on the hub , wherein the plastic deformation step has the effect of deforming the hub by forming a boss to fill a space of the notch , so as to rotatably block the hub on the part .
An inhibitor of N-methyl-D-aspartate type of glutamate receptor (NMDAR) for use in the treatment of an Autism Spectrum Disorder (ASD) in a subject in need thereof, wherein the inhibitor of NMDAR is NitroSynapsin: wherein each R 1 is -CH 2 CH 3 and R 2 is -ONO 2 , or a pharmaceutically acceptable salt thereof.
A cleaning composition, comprising: 1) hydroxylamine in an amount of from 0.5% to 20% by weight of the composition; 2) at least one organic solvent selected from the group consisting of water soluble alcohols, water soluble ketones, water soluble esters, water soluble sulfones, and water soluble ethers, wherein water soluble alcohols, water soluble ketones, water soluble esters, water soluble sulfones, and water soluble ethers are substances having a solubility of at least 5% by weight in water at 25°C, and wherein the at least one organic solvent is in an amount of from 60% to 95% by weight of the composition; 3) at least one boron-containing compound selected from the group consisting of boric acid, boronic acids, and salts thereof, the at least one boron-containing compound being in an amount of 0.001% to 0.2% by weight of the composition; and 4) water. 1) hydroxylamine in an amount of from 0.5% to 20% by weight of the composition; 2) at least one organic solvent selected from the group consisting of water soluble alcohols, water soluble ketones, water soluble esters, water soluble sulfones, and water soluble ethers, wherein water soluble alcohols, water soluble ketones, water soluble esters, water soluble sulfones, and water soluble ethers are substances having a solubility of at least 5% by weight in water at 25°C, and wherein the at least one organic solvent is in an amount of from 60% to 95% by weight of the composition; wherein water soluble alcohols, water soluble ketones, water soluble esters, water soluble sulfones, and water soluble ethers are substances having a solubility of at least 5% by weight in water at 25°C, and wherein the at least one organic solvent is in an amount of from 60% to 95% by weight of the composition; 3) at least one boron-containing compound selected from the group consisting of boric acid, boronic acids, and salts thereof, the at least one boron-containing compound being in an amount of 0.001% to 0.2% by weight of the composition; and 4) water.
Use of brazzein for synergistically enhancing the sweet taste and/or the sweetness quality of a sweet-tasting substance in a preparation comprising a sweet-tasting substance selected from the group consisting of sucrose, sucralose, acesulfam-K, Na-cyclamate, saccharin, glucose, fructose, lactose or xylit, wherein the concentration of brazzein is from about 1 mg/L to about 100 mg/L, based on the total preparation
A method for the determination of the presence of an anti-drug antibody (ADA) against an effector function suppressed human or humanized drug antibody (EFS-DA) in a sample comprising the following steps in the following order: - incubating a sample comprising mammalian blood serum with full length human Fcgamma receptor I or an Fc-region binding fragment thereof so that a complex between the ADA present in the sample and the human Fcgamma receptor I or the Fc-region binding fragment thereof forms, whereby the full length human Fcgamma receptor I or the Fc-region binding fragment thereof is conjugated to a detectable label, and - determining the complex formed in the previous step by the detectable label. - incubating a sample comprising mammalian blood serum with full length human Fcgamma receptor I or an Fc-region binding fragment thereof so that a complex between the ADA present in the sample and the human Fcgamma receptor I or the Fc-region binding fragment thereof forms, whereby the full length human Fcgamma receptor I or the Fc-region binding fragment thereof is conjugated to a detectable label, and - determining the complex formed in the previous step by the detectable label.
A suspension device for suspending sausages , in particular sausage chains, comprising a plurality of circulating suspension hooks , wherein the suspension device comprises an integrated weighing unit for weighing at least one sausage or at least one sausage chain , wherein at least one suspension hook is connected to a weighing cell such that the weight of the at least one sausage or sausage chain can be determined on the suspension hook characterized in that the suspension device comprises a circulating drive element in engagement with the suspension hooks , wherein, for the purpose of weighing, the suspension hooks to be weighed can be decoupled from the drive element .
A method of monitoring component health, the method comprising locating an elevator rail, rope or belt health monitor on an elevator car or on another similarly movable component of an elevator system : moving the elevator rail, rope or belt health monitor over a scattering surface of the monitored component; emitting light (122a-122c) of various wavelengths toward the scattering surface from a light source (120a-120c) of the elevator rail, rope or belt health monitor ; observing one or more responses of the scattering surface to the light of the various wavelengths at a detector (130a-130c) of the elevator rail, rope or belt health monitor ; and identifying a condition of the scattering surface from the observed one or more responses of the scattering surface to the light of the various wavelengths (122a-122c). moving the elevator rail, rope or belt health monitor over a scattering surface of the monitored component; emitting light (122a-122c) of various wavelengths toward the scattering surface from a light source (120a-120c) of the elevator rail, rope or belt health monitor ; observing one or more responses of the scattering surface to the light of the various wavelengths at a detector (130a-130c) of the elevator rail, rope or belt health monitor ; and identifying a condition of the scattering surface from the observed one or more responses of the scattering surface to the light of the various wavelengths (122a-122c).
Glass intended to close an optical housing for a motor vehicle, comprising a partition and at least one light guide , the partition is at least partially opaque and in this that at least one light guide passes through said partition so that a proximal end of the light guide faces a internal face of the partition and that a distal end of the light guide faces an external face of the partition , characterized in that the internal face of the partition is covered by a transparent support layer , and in that the support layer also covers a proximal end of at least one light guide passing through the partition .
A method for displaying additional information of a web page, comprising: analyzing code for a web page to be displayed by a web browser application on a first device to identify an actionable area on the web page, the code having additional information corresponding to the actionable area and the code being configured such that if the web page is displayed with a second device, the second device different from the first device and having a positioning cursor, the additional information is displayed in response to a floatover by the positioning cursor of the second device, wherein the first device does not include a positioning cursor; replacing or augmenting the actionable area in the display of the web page by the web browser application on the first device with a visual cue (415; 530; 600), prior to user interaction with the displayed web page, to suggest a user gesture to effectuate selection of the actionable area ; identifying a user motion directed at the web browser application running on the first device; identifying the user motion as an input gesture; processing the input gesture to determine a selection of the actionable area ; and providing the selection to the web browser application to enable the additional information to be displayed on the first device. analyzing code for a web page to be displayed by a web browser application on a first device to identify an actionable area on the web page, the code having additional information corresponding to the actionable area and the code being configured such that if the web page is displayed with a second device, the second device different from the first device and having a positioning cursor, the additional information is displayed in response to a floatover by the positioning cursor of the second device, wherein the first device does not include a positioning cursor; replacing or augmenting the actionable area in the display of the web page by the web browser application on the first device with a visual cue (415; 530; 600), prior to user interaction with the displayed web page, to suggest a user gesture to effectuate selection of the actionable area ; identifying a user motion directed at the web browser application running on the first device; identifying the user motion as an input gesture; processing the input gesture to determine a selection of the actionable area ; and providing the selection to the web browser application to enable the additional information to be displayed on the first device.
A compound selected from: N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide, or a pharmaceutically acceptable salt thereof; and N-[2-(diethylamino)ethyl]-2-{2-[2-(2,3-difluorophenyl)ethyl]-4-oxo-4,5,6,7-tetrahydro-1Hcyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluoromethyl)-4-biphenylyl]methyl}acetamide bitartrate, or a pharmaceutically acceptable salt thereof; and 2-[[(2,3-difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1 -quinolineacetamide, or a pharmaceutically acceptable salt thereof; and N-[2-(dimethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-5-(1-methyl-1H-pyrazol-4-yl)methyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1 -pyrimidineacetamide, or a pharmaceutically acceptable salt thereof, for use in treating and/or preventing macular edema in a subject. N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide, or a pharmaceutically acceptable salt thereof; and N-[2-(diethylamino)ethyl]-2-{2-[2-(2,3-difluorophenyl)ethyl]-4-oxo-4,5,6,7-tetrahydro-1Hcyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluoromethyl)-4-biphenylyl]methyl}acetamide bitartrate, or a pharmaceutically acceptable salt thereof; and 2-[[(2,3-difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1 -quinolineacetamide, or a pharmaceutically acceptable salt thereof; and N-[2-(dimethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-5-(1-methyl-1H-pyrazol-4-yl)methyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1 -pyrimidineacetamide, or a pharmaceutically acceptable salt thereof, for use in treating and/or preventing macular edema in a subject.